fda-device · Food and Drug Administration · Rule · Published 2016-06-15 · Effective 2016-09-13 · 81 FR 38911
Document
Document number
2016-13989
Federal Register citation
81 FR 38911
CFR reference
21 CFR 660
Type
Rule
Action
Final rule.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2016-06-15
Effective date
2016-09-13
HHS docket
Docket No. FDA-2013-N-0125
Abstract
The Food and Drug Administration (FDA or the Agency) is issuing this final rule revising its medical device and certain biological product labeling regulations to explicitly allow for the optional inclusion of graphical representations of information, or symbols, in labeling (including labels) without adjacent explanatory text (referred to in this document as "stand-alone symbols") if certain requirements are met. The final rule also specifies that the use of symbols, accompanied by adjacent explanatory text continues to be permitted. FDA is also revising its prescription device labeling regulations to allow the use of the symbol statement "Rx only" or "[rx] only" in the labeling for prescription devices.